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Purpose: Microbeam radiation therapy (MRT) uses narrow planes of high dose radiation beams to
treat cancerous tumors. This experimental therapy method based on synchrotron radiation has been
shown to spare normal tissue at up to 1000 Gy of peak entrance dose while still being effective in
tumor eradication and extending the lifetime of tumor-bearing small animal models. Motion during
treatment can lead to significant movement of microbeam positions resulting in broader beam width
and lower peak to valley dose ratio (PVDR), which reduces the effectiveness of MRT. Recently,
the authors have demonstrated the feasibility of generating microbeam radiation for small animal
treatment using a carbon nanotube (CNT) x-ray source array. The purpose of this study is to incorpo-
rate physiological gating to the CNT microbeam irradiator to minimize motion-induced microbeam
blurring.
Methods: The CNT field emission x-ray source array with a narrow line focal track was operated at
160 kVp. The x-ray radiation was collimated to a single 280 μm wide microbeam at entrance. The
microbeam beam pattern was recorded using EBT2 Gafchromic c© films. For the feasibility study,
a strip of EBT2 film was attached to an oscillating mechanical phantom mimicking mouse chest
respiratory motion. The servo arm was put against a pressure sensor to monitor the motion. The
film was irradiated with three microbeams under gated and nongated conditions and the full width
at half maximums and PVDRs were compared. An in vivo study was also performed with adult
male athymic mice. The liver was chosen as the target organ for proof of concept due to its large
motion during respiration compared to other organs. The mouse was immobilized in a specialized
mouse bed and anesthetized using isoflurane. A pressure sensor was attached to a mouse’s chest to
monitor its respiration. The output signal triggered the electron extraction voltage of the field emission
source such that x-ray was generated only during a portion of the mouse respiratory cycle when
there was minimum motion. Parallel planes of microbeams with 12.4 Gy/plane dose and 900 μm
pitch were delivered. The microbeam profiles with and without gating were analyzed using γ -H2Ax
immunofluorescence staining.
Results: The phantom study showed that the respiratory motion caused a 50% drop in PVDR from
11.5 when there is no motion to 5.4, whereas there was only a 5.5% decrease in PVDR for gated
irradiation compared to the no motion case. In the in vivo study, the histology result showed gating
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increased PVDR by a factor of 2.4 compared to the nongated case, similar to the result from the
phantom study. The full width at tenth maximum of the microbeam decreased by 40% in gating in
vivo and close to 38% with phantom studies.
Conclusions: The CNT field emission x-ray source array can be synchronized to physiological sig-
nals for gated delivery of x-ray radiation to minimize motion-induced beam blurring. Gated MRT re-
duces valley dose between lines during long-time radiation of a moving object. The technique allows
for more precise MRT treatments and makes the CNT MRT device practical for extended treatment.
© 2014 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4886015]
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1. INTRODUCTION
1.A. Microbeam radiation therapy (MRT)
MRT is an experimental therapy method that uses arrays of
microscopically thin planar x-ray radiation for the treatment
of various radio-resistant and deep seated tumors.1 Experi-
mentally discovered at the Brookhaven National Laboratory2
and soon afterwards studied at the European Synchrotron Ra-
diation Facilities3, 4 it was shown to have the extraordinary
ability of ablating brain tumors while sparing normal tissue
in a variety of animals.5 The absorbed dose threshold for tis-
sue damage using micrometer-width beams was on the order
of 103 Gy, orders of magnitude higher than that for broad
beam radiation.4–7 Synchrotron microbeams are generally 25–
75 μm in width and spaced 100–200 μm center to center.6
Studies have shown normal tissue sparing effect is preserved
at up to ∼700 μm beam width8 as long as the valley doses
are kept under the threshold values. An experimental irradia-
tion of the spinal cords, using 680 μm wide beams at 400 Gy,
showed that three of the four rats tested had no paralysis or
behavioral changes.8 Both in vitro and in vivo studies have
shown evidence of tumor death and lifespan increase from
MRT treatments.9, 10
One of the factors in determining the effectiveness of MRT
treatment is the measurement of the valley dose—the dose be-
tween the microbeams. The peak to valley dose ratio (PVDR)
in synchrotron studies ranges from 10 to 100 s depending on
the procedure. Though the actual biology behind the treat-
ment is not fully understood, a possible explanation is the in-
creased vascular damage from loss of endothelial cells in the
tumor versus healthy tissue after MRT beam exposure.11 One
of the theories behind MRT is based on a valley dose below
the threshold value for normal tissue damage in the normal
tissue region.8, 12 Other groups have postulated bystander ef-
fects and cellular communication mechanisms resulting in the
tumor cell death from MRT treatment.
Although the concept has been around for decades,13 it has
only been successfully implemented so far only at a few syn-
chrotron light sources around the world.14, 15 The ultra-high
dose rates (>100 Gy/s) allow for the instantaneous deliv-
ery of the high dose in tens of milliseconds, thus maintain-
ing the microbeam profile despite the physiological motion
which is on the order of hundreds of micrometers and the
time scale of 100 s of milliseconds. Another reason that so far
the method could not be implemented with sources other than
synchrotron is that the near parallel beam and high dose rate
make it easier to collimate the beam into parallel microplanar
beams. However, being limited to a synchrotron facility for
beam generation poses problems for clinical studies.
1.B. Compact image guided MRT system for small
animal treatment
Taking advantage of the unique capabilities of the car-
bon nanotube (CNT) x-ray source array technology,16, 17 we
have recently demonstrated the feasibility of compact image-
guided MRT system for treatment of small animal tumor
models.18, 19 The device utilizes a specially designed CNT x-
ray source array made of individual units with long and nar-
row focal tracks to deliver the radiation simultaneously from
different directions, instead of from a single point, to the re-
gion of interest.18 An external collimator is used to collimate
the radiation into a microbeam of adjustable beam width. A
higher dose rate is achieved by distributing the electron en-
ergy over the long focal tracks with increased heat capacity
when compared to conventional microfocus x-ray tubes. The
microbeam irradiator is integrated with a homemade micro-
CT scanner for image guidance. A microbeam peak dose rate
of 2 Gy/s and average dose rate of 1.4 Gy/min are measured in
the first generation CNT microbeam irradiator.18 The average
dose rate is expected to be increased to 20 Gy/min in the sec-
ond generation device, currently under construction, with im-
proved anode thermal management. Targeted delivery of the
microbeam to the brain tumor site in mouse has been demon-
strated using a combined MRI and onboard x-ray projection
imaging procedure.20
Using the compact microbeam irradiator with an inevitably
lower dose rate compared to what is used in synchrotron MRT
experiments, it is necessary to minimize physiological motion
induced microbeam blurring. MRT research so far is mainly
focused on the brain tumors. The largest intracranial pulsation
in humans occurs in the optic chiasm with peak displacement
of 240 μm, with the brain stem, midbrain, and medulla dis-
placed by 200 μm.21 Brain movement is correlated with the
cardiac cycle.21 This motion during the exposure time will
broaden the width of the radiation track and potentially reduce
the effectiveness of the microbeam radiation. Motion blur
will become more prevalent in the abdomen due to breath-
ing. Unlike traditional thermionic x-ray sources and, in this
matter, the synchrotron sources, field emission x rays can be
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FIG. 1. (a) Isolated view of the cathode assembly showing the five cathodes producing a focal line on the anode. (b) Side cutaway view of the MRT tube
showing the electron beam from the cathodes hitting the anode and producing the fan beam which is then collimated to a microbeam. (c) 3D model of the MRT
and micro-CT image guided therapy system. (d) Picture of the desktop MRT system with integrated micro-CT mounted on the optical table.
modulated electronically by an arbitrary signal such as respi-
ration and cardiac signals.22, 23 Respiration and cardiac gating
has already been applied in vivo with small animal CT imag-
ing with better than 100 μm accuracy.23, 24
The goal of the study is to implement physiological gating
of our CNT x-ray source array based MRT system to min-
imize motion blurring and to increase the PVDR by elimi-
nating radiation during mouse motion. The effectiveness of
gating was first evaluated using a mechanical phantom with
simulated respiratory motion and then using a mouse model.
The liver was chosen as the target due to its large size, its
motion inside the body directly resulting from respiration,
and its ease of γ -H2Ax staining to determine the irradiation
pattern.
2. METHODS
2.A. Desktop MRT system
The image guided MRT system is shown in Fig. 1. The
CNT microbeam irradiator is integrated with a homemade
micro-CT scanner,25, 26 a precision mouse-positioning device,
a gas anesthesia unit, and physiological monitoring capabil-
ity. To increase the throughput, two mice can be irradiated at
the same time with independent anesthesia and physiological
monitoring capacity.
The specially designed linear CNT x-ray source array, as
described in previous publications,18 consists of a linear CNT
cathode which emits electrons under a bias extraction field,
a gating electrode, an electrostatic focusing lens to focus
the electron beam, and an opposing stationary tungsten an-
ode. The electron beam is focused down to a narrow 0.145
× 160 mm focal track on the anode. The x-ray source array
is operated at 160 kVp anode voltage and a tube current of
30 mA. The mean energy is 60 keV and the HVL was de-
termined to be 7.5 mm Al.18 The intrinsically divergent ra-
diation is collimated into microbeam using a motorized mi-
crobeam collimator placed between the x-ray window and the
object, 65.2 mm below the focal spot on the anode. In the
present system, parallel planes of microbeams are delivered
by translating the object in the direction perpendicular to the
microbeam plane in a step and shoot fashion. A PVDR of 16
was obtained at 4:1 pitch/width ratio and 280 mm beam width,
measured 124 mm below the focal spot or 58.8 mm below
the collimator. The beam spread angle was calculated to be
0.15◦.20
The gate mesh, which is directly above the CNT substrates
on the cathodes, is grounded, the anode is set to 160 kVp,
and the cathodes are pulsed from ground to a negative voltage
using a pulse generator to produce x rays at scheduled inter-
vals. In regular experiments where gating is not used, the tube
is operated at an 8% duty cycle using 500 μs width pulses.
The pulse diagram for the gated system can be seen below in
Fig. 4. The beam delivers an average dose rate of approxi-
mately 1.4 Gy/min at entrance. The dose is measured using
EBT2 Gafchromic c© dosimetry film. The dosimetry film is
calibrated by comparing the average of the red, green, and
blue channels of the film to ion chamber measurements.18
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FIG. 2. Schematic of phantom using servo motor arm simulating mouse ab-
dominal motion during breathing. The arm is always in contact with the foam
pad and the pressure sensor and oscillates in the direction shown.
2.B. Physiological motion monitoring
A physiological monitoring and triggering system
(BioVet c©, Spin Systems, South Brisbane, Australia) is
used to monitor the respiratory motion. The respiration
signal is obtained from a sensor pad placed on the surface
of the animal under the abdomen to monitor chest cavity
motion.23, 24, 26 The respiration sensor is a foam pad encased
in a rubber shell attached to thin tubing running into the
sensor processor. The signal measures the pressure change in
the tubing caused by the compression of the foam.
2.C. Mechanical phantom
We designed a phantom to simulate mouse chest respira-
tory motion using a servo motor. A 50 mm long plastic arm
attached to the servo was equipped with a Gafchromic film
strip and set in contact with a pressure sensor. The arm was
set to rotate 1◦ with a period of 800 ms and a 25% duty cy-
cle, equating to a motion of about 1 mm which mimics ac-
tual mouse breathing motion of the abdomen.27 The setup is
shown in Fig. 2.
Previous gating experiments23 have shown that the respi-
ration signal is nonsinusoidal and causes major motion 25%
of the time and a relaxed period between breaths 75% of the
time. A sample respiratory signal is shown in Fig. 3. The verti-
cal axis is a differential pressure measurement which is corre-
FIG. 3. BioVet c© differential pressure measurement, correlated to chest dis-
placement, compared to the phantom angular displacement.
lated to the chest displacement. The angular displacement of
the servo is shown as a function of time and closely matches
an actual respiration signal.
2.D. Mouse model and handling
For the in vivo MRT studies, adult male athymic mice are
used. The mouse is placed in a mouse holder 3D printed us-
ing fused deposition modeling. The mouse is first sedated
in an induction chamber and quickly moved onto the mouse
stage. The stage holds an anesthesia tube that pumps 1.5%–
2% isofluorane and oxygen mixture directly to the mouse’s
nose. For body irradiations, the mouse is positioned on its side
and taped down with medical tape to immobilize it. Exper-
imental procedures carried out in this study were approved
by the Institutional Animal Care and Use Committee at our
institution.
2.E. Respiratory gated irradiation
Figure 3 shows a typical respiratory signal from anes-
thetized mouse. As it is shown here, there is a periodically
short period of time between two inhalations where the chest
is not moving as much. Using this respiratory signal, the con-
stant radiation can be broken up into pulses to irradiate only
triggered at the end of the inhalation and last during these
“motionless” states. The gating program on the MRT control
FIG. 4. X-ray exposure pulse diagram. The top is the BioVetc output of the respiratory motion from the pressure sensor attached to the mouse. The threshold is
set by the operator as low as possible but still having the “motionless” state below it. The second pulse sequence shows the delay pulses that start the irradiation
on a high-to-low trigger. The last sequence shows the cathode pulses that generate the x-rays. The cathodes are negatively pulsed at 500 μs pulse widths with an
8% duty cycle.
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FIG. 5. Diagram of histology section plane.
system runs as follows. The settings are based on individual
mice and after the mouse is positioned, the operator waits for
its breathing to stabilize while adjusting the anesthesia dose
as necessary. During this time, the program reads in several
breaths to help the operator get a general idea of the signal.
A minimum threshold is set such that the “motionless” base-
line is completely underneath it, shown in Fig. 4, which sets
up the triggers. The operator then determines the “on” time
of irradiation by setting a 10% and 20% buffer at the begin-
ning and end of the pulses, respectively. In the sample respi-
ratory waveform from Fig. 3, the “motionless” state is 500 ms
long. This requires a 50 ms delay buffer at the beginning and
a 100 ms buffer at the end, making the “on” time 350 ms. The
pulse diagram is summarized in Fig. 4.
The operator then sets a minimum period allowed, gen-
erally within 10% of the current period, which shuts off the
pulses if crossed and indicates that the mouse is breathing
faster and waking up. Because it is normal for the mouse
to involuntarily twitch at times and breathe faster for a few
breaths, the program reads in and averages the last six trig-
FIG. 6. Single beam dose curves for three 5 min irradiations at 160 kVp.
FIG. 7. Three beam dose curves for three 5 min/line irradiations at 160 kVp.
gers to determine whether or not to turn off the irradiation.
After the mouse is stabilized, the program can be turned back
on to resume the treatment.
2.F. Irradiation protocols
2.F.1. Mechanical phantom
Two types of experiments were run. The first was a single
line irradiation at 160 kVp delivering 1.4 Gy/min for 5 min.
The second was a three line irradiation, separated by 900
μm with the same irradiation conditions for each line. We
recorded the dose profile by irradiating EBT2 Gafchromic c©
dosimetry film and scanning and processing the resulting
lines.
2.F.2. Mouse study
We ran an in vivo gated irradiation experiment with three
microbeam lines. The liver was chosen as the target organ
for a proof of concept study due to its large motion during
respiration compared to other organs. The liver location was
confirmed through a single 2D projection x-ray using the in-
tegrated micro-CT imaging system. The beams are marked
in relation to the location of the liver. Each line was separated
by 900 μm center-to-center and was delivered 12.4 Gy, which











12.4 Gy = 53.3 s irradiation on time,
53.3 s
500 μs/pulse
= 106 600 pulses.
The first two lines were delivered without gating as a con-
trol and the third line was gated to the respiration motion.
The irradiation times for each line were 11, 11, and 33 min,
respectively.
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FIG. 8. Mouse in the mouse bed post-treatment with MRT beam lines shown on EBT2 Gafchromic c© dosimetry film taped to bed.
2.G. Histology
To confirm the beam placement, γ -H2AX immunofluores-
cence staining is used as a quantitative biomarker of radiation-
induced DNA double-strand breaks.28 The mouse was euth-
anized 1 h after treatment and its body still in the bed was
fixed in formalin for 24 h to preserve the liver orientation
during transport from the radiation site to the tissue facility.
The formalin allowed the body and all internal organs to re-
main on the mouse bed exactly how it was during irradiation.
The liver was then carefully removed, noting the orientation,
and the tissue was embedded in paraffin and sectioned into
5 μm slices in the plane perpendicular to and following the
microbeams, shown in Fig. 5.
The staining protocol was as follows: The tissue slice was
hydrated and underwent antigen retrieval process by incu-
bated with citrate buffer. The sample was then incubated with
the primary antibody (Phosphohistone H2AX Rabbit anti-
mouse antibody, Cell Signaling Technology, Inc.) for 60 min,
followed by incubation with secondary antibody with Cy5
Tyramide and DAPI counterstaining on the nuclei. The sec-
tion was then scanned using a fluorescence slide scanner sys-
tem (Scanscope FL scanner, Aperio, Inc., Vista, CA) to obtain
γ -H2Ax stained images.
FIG. 9. γ -H2Ax staining of a liver cross section showing gated and non-
gated lines. The stained points show DNA double strand breaks which is
proportional to the dose delivered.
3. RESULTS
3.A. Film results from phantom study
In the single beam case, the film was scanned and ana-
lyzed using Film QA Pro c© from Ashland Advanced Material
Group. The program determines the shape of the dose pattern
along with the dose delivered. Figure 6 shows an example of
dose profiles for a single microbeam in three cases: no mo-
tion, motion without gating, and motion with gating.
A more important quantity for the effectiveness of the
MRT is the PVDR for the multiple line case. Figure 7 shows
the beam profiles for three-line irradiations. Here, we see how
that shelf in the single line affects the PVDR of the multiline
set. The motion causes a 50% drop in PVDR from 11.5 to
5.4 but by effective gating, one can almost recover the PVDR
value. There is only 5.5% decrease in PVDR in the case of
motion with gating compared to the no motion case. There is
also small drop in the peak dose from 3.4 to 3.2 Gy.
3.B. Histology results from mouse study
Figure 8 shows the mouse post-treatment with the beam
lines shown on the Gafchromic film attached to the edge of
the mouse bed.
FIG. 10. Double strand break profile of the γ -H2Ax stain in Fig. 9.
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Figure 9 shows the γ -H2Ax stained liver sample that high-
lights double stranded breaks in the DNA from radiation dam-
age to the tissue. The microbeams are clearly seen and their
plot profiles are shown in Fig. 10. The gated PVDR increased
by a factor of 2.4 as compared to the nongated lines. This is
close to the 2.0 factor increase in the phantom study. The full
width at tenth maximum (FWTM) decreased by 40% by gat-
ing. This is also close to the 38% decrease seen in the phantom
study.
4. DISCUSSION AND CONCLUSION
In this paper, we have shown that physiologically gated
MRT is possible using our CNT based field emission mi-
crobeam irradiator. We have demonstrated that motion gating
reduced valley dose and enhanced PVDR between the lines
during long-time irradiation.
From the phantom study, when there is no motion, the
full width at half maximum (FWHM) of the dose profile is
approximately 440 μm, which is expected from geometri-
cal consideration of the beam spread versus the height. The
280 μm beam width is obtained 1 cm below the collima-
tor during mouse irradiations but as the phantom was much
larger, it had to be placed about 13 cm below which broadened
the beam to 440 μm. When the phantom motion is turned on,
the broadening of the dose profile due to motion is clearly
seen in the motion control as a side tail.
The FWHM of all curves is the same because the motion
was not sinusoidal. Had it been, the peak would have truly
“broadened” but since the motion was driven by a 25% duty
cycle pulse, the movement contribution is seen as the 0.5 Gy
shelf to the left. A more accurate measurement would be to
look at the FWTM. FWTM increases from 638 to 1088 μm
when the motion is turned on. By applying gating the FWTM
is reduced back to 669 μm, almost the same as that without
motion.
The irradiation time during gating notably increased from
11 to 33 min to deliver the same dose. This is because of the
off-time enforced during the respiratory motion of the ani-
mal. Our tube is run at an 8% duty cycle of 500 μs pulses to
prevent overheating, but during gating, the effective duty cy-
cle was dropped to 2.7% due to the stops ( 11 min33 min × 8%). As-
suming the animal’s breathing remains mostly constant dur-
ing the procedure, we can recover this extra treatment time
simply by increasing the duty cycle of the pulses by the factor
Treatment time with gating
Treatment time with 8% duty cycle , or in our case 8% × 33 min11 min = 24%.
We further demonstrated its therapy capability of free-
breathing mice under their natural position without forced
ventilation. With free-breathing, there is no need to do intuba-
tion for forced ventilation, thus reducing any damage due to
the intubation procedure. Free-breathing also eliminates pos-
sible ventilation problems due to changes of tidal volume dur-
ing treatment, reducing anesthesia caused mortality in forced
ventilation.
The technique presented here showed a proof-of-concept
method of gated radiation treatment. The liver was chosen due
to its increased motion during breathing and the ease of radia-
tion detection using γ -H2AX staining. This technique can be
expanded to other areas of the body and can be gated to other
physiological signals, such as the cardiac cycle.
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